Patient P-01536
Synthetic patientNBL-101 · Day 114 · 25–34 · F · baseline S13Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
5%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S13
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-11
- Inflammatory activity-8
- Nutritional resilience+7
- GI instability-4
- Treatment adherence+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion14.7/100
worsening · +5.0 vs previous 14 d
Toxicity
Blood1.2/100
improving · -6.2 vs previous 14 d
Sleep quality
Wearable42.6/100
stable · +0.2 vs previous 14 d
Energy level
Daily log7.4/10
stable · +0.1 vs previous 14 d
Stress level
Daily log4.4/10
stable · +0.1 vs previous 14 d
Steps
Wearable5,003
stable · +176 vs previous 14 d
Adherence
Companion91.9 %
stable · +2.5 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 94 from the failing basin, 8 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- Enterobacteriaceae elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
- Dietary driftperturbation · steering -2.6
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+1no signal · 32%
- Dietary fat load+0.3no signal · 15%
- Alcohol+0.3no signal · 15%
- Simple carbohydrates-0.1no signal · 15%
- Spicy / capsaicin-0.1no signal · 15%
- Insoluble fibre0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓15
- WearableHRV 38 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.5 · butyrate capacity 69/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 33 ms
- Sleep
- 6.9 h
- Steps
- 6,163
- Resting HR
- 60 bpm
Daily log: GI score 15, nutritional resilience 74, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01654 | 52% | S08 | CR-01 | improved | 85 |
| P-01796 | 51% | S09 | SC-12 | improved | 86 |
| P-01495 | 50% | S07 | BR-03 | improved | 85 |
| P-01791 | 48% | S06 | ME-01 | improved | 79 |
| P-01798 | 47% | S08 | NP-02 | improved | 78 |
| P-01671 | 46% | S04 | SC-12 | improved | 90 |
| P-01467 | 45% | S09 | HY-01 | improved | 79 |
| P-01439 | 43% | S18 | ME-01 | improved | 79 |
| P-01329 | 41% | S08 | BR-03 | improved | 79 |
| P-01625 | 40% | S06 | SC-12 | improved | 83 |
| P-01479 | 38% | S15 | DT-01 | improved | 84 |
| P-01855 | 36% | S04 | DT-01 | improved | 73 |